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Abstract. In two experiments with European eel 
(Anguilla anguilla L., 1758) the effects of flumequine 
(FQ), oxytetracycline (OTC) and furazolidone (FZ) on 
peripheral blood leucocytes were tested using measure- 
ments of differential white blood cell counts in blood 
smears, flow cytometry and respiratory burst activity of 
adherent cells. Results revealed that FQ and OTC 
affected (different) leucocyte populations, whereas no 
effect of FZ was detected in these experiments. These 
effects should be taken into account when drugs are 
registered for official approval in veterinary (fish) 
medicine. 
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Introduction 
The European eel (Anguilla anguilla L., 1758) is a 
teleost fish, highly appreciated as food in various 
countries. Because of the discrepancy between con- 
sumer demand and availability, eel farming is growing 
in European countries. In the initial culture phases, in 
particular, fish growth and survival are severely affected 
by non-acceptance of feed and infectious diseases 
(Heinsbroek 1989). The latter is connected with stress 
associated with the culture conditions (Peters et al. 
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1980). Stress is also a major cause for disease problems 
in more advanced culture phases. Next to parasitic 
diseases (Heinsbroek 1991), bacterial diseases, which 
often start as opportunistic infections, may become very 
serious (Tesch 1991). As a result, Koops and Kuhlmann 
(1983) stated that antibacterial drugs are indispensable 
for successful prediction in intensive eel farming. 
Bacterial diseases, mainly caused by Gram-negative 
bacteria, are predominantly controlled with the anti- 
bacterial drugs flumequine (FQ), oxytetracycline 
(OTC) and furazolidone (FZ). 
Like other vertebrates, fish possess an extensive 
defence system, including major lymphoid organs, such 
as kidney, spleen and thymus. The protective mechan- 
isms comprise non-specific reactions uch as physical 
and chemical barriers, non-specific cytotoxic cell 
activity and phagocytosis by macrophages and granulo- 
cytes, and specific reactions characterised by antigen 
specificity and memory formation (Lamers 1985). 
Imm{momodulation s a consequence of a change in 
quantity and/or function of the cells or substances 
involved in the immune responses. Next to natural 
immunoregulatory mechanisms, a number of drugs and 
environmental chemicals are known to induce alter- 
ations in the immune system. For fish there are several 
studies describing immunomodulating effects of anti- 
bacterial drugs (Rijkers et al. 1980, 1981; Grondel and 
Boesten 1982; Siwicki et al. 1989). 
To study possible immunomodulating effects, in 
order to support a more rational drug choice in cases of 
outbreaks of bacterial diseases, two experiments were 
performed in which the influence of FQ, FZ and OTC 
on peripheral blood leucocytes was investigated. This 
paper combines the results of those experiments. 
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Materials and Methods 
Fish 
In two experiments, non-sexed European eels (Anguilla 
anguiUa L., 1758) with a mean weight between 72 and 
120 g were used. Fish were obtained from a commercial 
eel farm and raised without any bacterial drugs in 
aquaria with aerated, running tap water at a tempera- 
ture of 23 + 0.5~ Two weeks before the start of the 
experiments he fish were randomly divided into three 
aquaria, treatments in both experiments being 
randomly allocated to an aquarium. During the experi- 
ments the fish were starved. 
Experimental Design 
The characteristics of the experiments are shown in 
Table 1. Manipulation of the animals was performed 
after sedation in water containing 300 ppm Hypnodil | 
(Janssen Pharmaceutica BV, Beerse, Belgium). FQ was 
used in both experiments, whereas FZ was tested in 
experiment 1 (exp. 1) and OTC in experiment 2 (exp. 
2). Following exposure to the test compounds, differen- 
tial counts of peripheral leucocytes, determination of
surface immunoglobulin-positive (slg § lymphoid cells 
by flow cytometry, and measurement of the respiratory 
burst activity of adherent cells were performed. 
Drug Administration 
In exp. 1, non-medicated and medicated feed slurries 
were freshl~ prepared. The latter contained 4 mg/ml FQ 
(Flumiquil ~, Pitman-Moore, Haarlem, The Nether- 
lands) or 10 mg/ml FZ (Smith-Kline, Zoetermeer, The 
Netherlands). The fish were dosed by intubation of the 
stomach, corresponding to a single administration f the 
generally used dose level of FQ or FZ (20 mg/kg and 50 
mg/kg body weight (bw), respectively). Control eels 
received acorresponding amount of unmedicated feed. 
In exp. 2, FQ or OTC (oxytetracycline-HCl; A.U.V., 
Cuijk, The Netherlands), dissolved in physiological 
saline, was administered by intramuscular (i.m.) 
injection at a dose of 10 mg/kg and 60 mg/kg bw, 
respectively. Control animals were sham treated by i.m. 
injection of an equivalent volume (2 ml/kg bw) of the 
vehicle. 
Sampling 
Blood was sampled at day 1 and 7 post-treatment (p.t.) 
(exp. 1) and day 3 and 17 p.t. (exp. 2), respectively 
(Table 1). 
Heparinised blood samples of 0.5 ml were collected 
from the caudal vein. Blood smears were prepared and 
air dried. The remaining blood was processed for flow 
cytometric determination a d/or espiratory burst test. 
Flow Cytometry 
The protocol used for determining the proportion of 
slg + cells was as described by Van der Heijden et al. 
(1995b). After centrifugation and removal of blood 
plasma, the peripheral blood cells were resuspended in 
adapted Roswell Park Memorial Institute medium 
(RPMI) (Gibco, Breda, The Netherlands). A lympho- 
cyte-enriched fraction was obtained by separating 
the cells over a discontinuous Percoll | (Pharmacia, 
Uppsala, Sweden) density gradient (1.020 and 1.070 g/ 
cm ~) and collecting the interphase. After washing, the 
cells were incubated with a mouse monoclonal anti- 
body, specifically reacting with the heavy chain of 
plasma and membrane-bound eel immunoglobulin 
(Van der Heijden et al. 1995a). Thereafter, the ceils 
were washed again and incubated with rabbit anti- 
mouse immunoglobulin conjugated to fluorescein 
isothiocyanate (RAM-FITC, Dakopatts, Glostrup, 
Denmark). After washing~ cells were analysed with a 
flow cytometer (FACStar ~, Becton Dickinson, Moun- 
tain View, CA, USA) and the Consort 30 data analysis 
package. In each sample, 104 cells were counted and 
only cells having the Foreward Scatter (FSC) and Side 
(90 ~ Scatter (SSC) of lymphoid cells were used for 
determination f slg + lymphoid (B) cells. 
Table 1. Experimental design 
Exp Nos of W Trmt Adm Parameters T Samp Time 
eel (g) (~ (days p.t.) 
1 3x10 72 FQ Oral sIg § Lymphocyte (%) 22.5 1, 7 
FZ Lymphocyte (%) 
2 3x24 120 FQ i.m. Lymphocyte (%) 23 3, 17 
OTC Leucocyte (%) 
Adherence 
Resp. Burst Activity 
Exp: Number of experiment; W: mean weight; Trmt: treatment; Adm: method of administration; T: water 
temperature; Samp Time: sampling time, days post treatment. 
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Blood Smears 
Blood smears were stained by the May-Griinwald- 
Giemsa method for differential counts of 100 white 
blood cells (granulocytes and lymphoid cells). Throm- 
bocytes were not regarded as white blood cells. 
Cell Adherence and Measurement ofRespiratory Burst 
Activity 
Phagocyte killing efficiency was measured by detection 
of intracellular superoxide anions by means of nitro- 
blue tetrazolium dye (NBT) reduction. Briefly, mono- 
layers of 10 6 peripheral leucocytes per well of a 96-well 
microtitre plate were prepared. After one hour, non- 
adhering cells were removed by rinsing in RPMI with- 
out Phenol Red. Thereafter, four wells in each plate 
were used for the estimation of the percentage of 
adhering cells by counting the nuclei after cell lysis by 
citric acid. 
Subsequently, NBT was added to the remaining 
wells, in which the monolayers were incubated for 90 
min at 25~ The formazan formed was determined 
using the optical density measured at 690 nm (Verburg- 
van Kemenade t al. 1994). 
Statistical Analysis 
Data were checked for normality and outliers by means 
of Wilk-Shapiro/rankit plots and box plots, respectively. 
Parameter values of the different treatments were 
examined by means of two-way analysis of variance 
(ANOVA). Pairwise comparison of means was per- 
formed using the least significant difference method 
(LSD T-test). Where possible the models were reduced 
by omitting non-significant interaction terms. All testing 
was performed with the computer program STATISTIX 
(1985) at a significance probability level of 5%. 
Resu l ts  
Fig. 1 shows a representative FSC/SSC profile of a 
lymphocyte nriched fraction of peripheral blood cells 
and the corresponding fluorescence histogram indicat- 
ing the separation between slg- and slg § lymphoid 
cells. The mean percentages of slg + lymphoid cells in 
peripheral blood of the different reatment groups in 
exp. 1 are shown in Fig. 2. A significantly lower mean 
proportion of slg + cells was observed in FQ-treated 
animals compared to FZ-treated and undosed controls. 
Moreover, FQ decreased the percentage of lymphoid 
cells in the peripheral blood on day 7 p.t. (Fig. 3). There 
was also a significant decrease in lymphoid cells between 
day 1 and 7 p.t. in all groups. In exp. 2 OTC suppressed 
the lymphoid cell percentage on day 3 p.t. This percent- 
age was not significantly influenced by FQ on either 
sample days (Fig. 4). 
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The number of adherent leucocytes was enhanced by 
OTC, but there was no significant difference in the 
number of adherent cells between FQ-treated and 
control animals on day 3 p.t. (Fig. 5). The activity of 
these adherent cells, measured by means of the NBT- 
test, was increased by FQ, whereas there was no 
significant difference in activity of these cells between 
OTC-treated and control animals on day 3 p.t. (Fig. 6). 
Discuss ion  
In experiment 1 FQ decreased the percentage of slg § 
lymphoid cells compared with the FZ-treated and con- 
trol animals. This might be due to a stimulating effect of 
this drug on the proliferation of slg- cells as suggested 
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Fig. 2. Mean percentages of slg + lymphocytes in peripheral blood of 
European eel (Anguilla nguilla) 7 days after peroral antibacterial 
treatment. Bars represent SD. Groups (n=10) with a different letter 
differ significantly at p<0.05. 
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Fig. 5. Number of adherent peripheral blood cells per 107 leucocytes, 
3 days after administration of flumequine (FQ) or oxytetracycline 
(OTC) compared with a control group. Bars represent SD. Groups 
(n=12) with a different letter differ significantly at p<0.05. 
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Fig. 3. Mean percentages of lymphoid cells in blood smears 1 and 7 
days after flumequine (FQ) or furazolidone (FZ) treatment compared 
with a control group. Bars represent SD. Groups (n=10) with a 
different letter differ significantly at p<0.05. 
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Fig. 4. Mean percentages of lymphoid cells in blood smears 3 and 17 
days after administration of flumequine (FQ) or oxytetracycline 
(OTC) compared with a control group. Bars represent SD. Groups 
(n = 12) with a different letter differ significantly at p<0.05, 
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Fig. 6. Respiratory burst activity of adherent peripheral blood 
leucocytes 3 days after flumeuine (FQ) or oxytetracycline (OTC) 
treatment compared with a control group. Data are expressed as 
absorbance measured at 690 nm per 105 leucocytes. Bars represent 
SD. Groups (n=12) with a different letter differ signifcantly at 
p<0.05. 
by Van der Heijden et al. (1995b). Because only the 
relative number of peripheral blood leucocytes was 
determined, it can be concluded that both FQ (exp. 1; 
day 7 p.t.) and OTC (exp. 2; day 3 p.t.) altered the 
proportions of peripheral blood lymphoid cells. The 
observed difference of the differential counts between 
day 1 and 7 of exp. 1 includes a sharp increase of the 
percentages of granulocytes in all treatment groups. 
This is caused by environmental stress during the first 
experimental week (Ellis 1977). However, the effect of 
these drugs on the absolute numbers of the different 
types of peripheral blood leucocytes remains to be 
investigated. 
Adherent peripheral blood leucocytes include mono- 
cytes and granulocytes. The increase of the latter in the 
peripheral blood by OTC (exp. 2) on day 3 p.t. is in 
agreement with the results of the differential count. 
Rijkers et al. (1980, 1981) demonstrated an increased 
number of granulocytes in the spleen of OTC-treated 
common carp. Although the number of adherent cells is " 
increased in OTC-treated animals, these ceils show 
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lower respiratory burst activity than the adherent cells 
of FQ-treated animals. This may have consequences for 
the intracellular killing and/or elimination of pathogenic 
micro-organisms. 
Results from pharmacokinetic research (Grondel et 
al. 1987) showed that OTC was accumulated and 
retained in scales, bone tissue and pronephros, one of 
the main lymphoid organs in carp (Rijkers et al. 1981). 
It was suggested that the negative influence of OTC on 
carp immune responses could be explained by the 
specific affinity of OTC for lymphoid tissues. Selective 
interference of xenobiotics, such as the antibacterial 
drugs used in these experiments, with cells of the 
-immune system (particularly lymphocytes), may be 
explained by an enhanced vulnerability of these cells as 
a consequence of a high division rate (Van der Heijden 
et al. 1992). Flumequine has been proven to have 
mitogenic properties in European eel (Van der Heijden 
et al. 1995b) and rainbow trout (Tanck et al. 1995). 
Moreover, lymphocytes possess hardly any organelles 
with abilities for detoxification. 
From the results of the present studies it can be 
concluded that commonly used doses of at least two 
drugs, often used in fish culture, are most likely to 
display clinically significant effects on the defence 
system of the eel. Such effects can be important for the 
choice of drugs in fish disease treatment. Drugs specifi- 
cally licensed for use in aquaculture are scarce in some 
countries, and not even available in others. Never- 
theless, drugs are regularly used at many eel farms 
against clinical bacterial infections. These medicines 
have been proven to be successful in the farming of 
chickens, pigs and cows. However, pharmacokinetics in
homeothermic and poikilothermic animals may differ 
significantly. Therefore, species-specific fish antibacter- 
ial drugs have to be developed and registered. Existing 
immunomodulating effects should be taken into account 
by the scientists involved in these registrations. Because 
a drug may have different effects on different parts of 
the immune system, it is advisable to develop a panel of 
standardised tests to estimate possible immunomodulat- 
ing properties of drugs used in fish. 
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